Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Intellia Therapeutics, Inc | NTLA

Daily Technical Analysis of Intellia Therapeutics, Inc

Intellia Therapeutics had a rough day and is now down -6.10%. Investors weren't too impressed with the future outlook for the Biotechnology company which caused some selling on weak demand.

Currently NTLA isn't at a clear support/resistance line that seems tradable. Intellia Therapeutics hasn't been looking too hot recently, some shareholders have been dumping shares over the last few months which has been driving prices down. In the past 3 months, the Biotechnology company has lost -26.59 of it's value. So it's not looking great, I'd probably wait for a clearer support level before coming in. NTLA might find some support at the 27.91 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Intellia Therapeutics By Price Target And Rating

The analysts are pretty neutral on Intellia Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is -5.01. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. The Goldman Sachs Group downgraded from Buy to Neutral on 2024-02-23 and they lowered their price target by -76.47% to $32.00 from a previous target of $136.00. On 2024-02-23 Canaccord Genuity Group increased their price target by 1.39% to $73.00. On 2024-02-15 there was confirmation of the previous rating by Wedbush which was Neutral and provided a price target of $29.00. On 2024-02-15 Wolfe Research started covering Intellia Therapeutics with a rating of Peer Perform. Oppenheimer announced a lowering of their price target to $70.00 from $80.00 on 2023-11-13. Morgan Stanley announced a lowering of their price target to $85.00 from $90.00 on 2023-11-13. Raymond James announced a lowering of their price target to $57.00 from $78.00 on 2023-11-10. BMO Capital Markets provided a price target decease of -3.13% to $62.00 from $64.00 on 2023-11-10. Royal Bank of Canada announced a lowering of their price target to $70.00 from $80.00 on 2023-11-10. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-09-13 and they set their price target at $65.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
NTLA-5.011.32-4.251.5-8.59

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-23)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
NTLA0.000.00

Short interest for Intellia Therapeutics

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
NTLA10.46%10.9119.72.648120000

How Intellia Therapeutics compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
94-0.791.401.678.7412.3336.0055.327.466.693.83-13821.22-13102.4117.024.799.387.32
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
229-0.461.461.966.149.7026.2653.759.208.748.51-12620.24-12033.0919.004.266.734.83

Social Sentiment for Intellia Therapeutics

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
NTLA

Companies with the highest correlation to Intellia Therapeutics

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
TWST | Twist Bioscience Corporat1.61-1.137.3215.2822.13-5.8794.33571.934.073.73178.09-19226.760023.3961
EDIT | Editas Medicine, Inc. Com1.56-6.62-7.47-34.46-45.76-63.48-81.4947-172.46-138.74-176.20-57394.912.090016.4101
BEAM | Beam Therapeutics Inc. Co1.47-4.824.2212.5413.879.96-8.90711.27-0.36-3.90-1399.55-9300.67150018.782
CRSP | CRISPR Therapeutics AG1.44-5.265.963.7514.61-12.51-26.9356-22.71-24.19-28.44-6526.20-3384.340015.3247
MGNI | Magnite, Inc. Common Stoc1.140.353.3638.0034.9826.65101.52989.8216.5419.660.00-23759.19005.9574
VCYT | Veracyte, Inc.1.12-2.730.1819.4444.3096.7764.617587.7754.0728.480.00-24528.4315004.97884

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-